Cargando…
Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802530/ https://www.ncbi.nlm.nih.gov/pubmed/29233975 http://dx.doi.org/10.1038/s41408-017-0006-y |
_version_ | 1783298537090449408 |
---|---|
author | Schalling, Martin Gleiss, Andreas Gisslinger, Bettina Wölfler, Albert Buxhofer-Ausch, Veronika Jeryczynski, Georg Krauth, Maria-Theresa Simonitsch-Klupp, Ingrid Beham-Schmid, Christine Thiele, Jürgen Gisslinger, Heinz |
author_facet | Schalling, Martin Gleiss, Andreas Gisslinger, Bettina Wölfler, Albert Buxhofer-Ausch, Veronika Jeryczynski, Georg Krauth, Maria-Theresa Simonitsch-Klupp, Ingrid Beham-Schmid, Christine Thiele, Jürgen Gisslinger, Heinz |
author_sort | Schalling, Martin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5802530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-58025302018-02-08 Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data Schalling, Martin Gleiss, Andreas Gisslinger, Bettina Wölfler, Albert Buxhofer-Ausch, Veronika Jeryczynski, Georg Krauth, Maria-Theresa Simonitsch-Klupp, Ingrid Beham-Schmid, Christine Thiele, Jürgen Gisslinger, Heinz Blood Cancer J Correspondence Nature Publishing Group UK 2017-12-13 /pmc/articles/PMC5802530/ /pubmed/29233975 http://dx.doi.org/10.1038/s41408-017-0006-y Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correspondence Schalling, Martin Gleiss, Andreas Gisslinger, Bettina Wölfler, Albert Buxhofer-Ausch, Veronika Jeryczynski, Georg Krauth, Maria-Theresa Simonitsch-Klupp, Ingrid Beham-Schmid, Christine Thiele, Jürgen Gisslinger, Heinz Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data |
title | Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data |
title_full | Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data |
title_fullStr | Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data |
title_full_unstemmed | Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data |
title_short | Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data |
title_sort | essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802530/ https://www.ncbi.nlm.nih.gov/pubmed/29233975 http://dx.doi.org/10.1038/s41408-017-0006-y |
work_keys_str_mv | AT schallingmartin essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata AT gleissandreas essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata AT gisslingerbettina essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata AT wolfleralbert essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata AT buxhoferauschveronika essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata AT jeryczynskigeorg essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata AT krauthmariatheresa essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata AT simonitschkluppingrid essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata AT behamschmidchristine essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata AT thielejurgen essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata AT gisslingerheinz essentialthrombocythemiavsprefibroticearlyprimarymyelofibrosisdiscriminationbylaboratoryandclinicaldata |